Scotland covid-19 vaccine medicines Scotland

Small risk of bleeding disorder after AstraZeneca COVID vaccine

Reading now: 160
www.cidrap.umn.edu

A study of 5.4 million Scottish adults has revealed a small increased risk of an autoimmune bleeding disorder after the first dose of the AstraZeneca/Oxford COVID-19 vaccine, although a causal link hasn't been established.The study, led by University of Edinburgh researchers and published today in Nature Medicine, assessed the risk of bleeding-related events among 2.53 million people (57.5% of the population of Scotland 18 and older) up to 27 days after the first dose of the AstraZeneca or Pfizer/BioNTech vaccine from December 2020 to April 2021.Of the 2.53 million, more than 1.7 million received the AstraZeneca vaccine, while about 800,000 received the Pfizer version.The risk of the autoimmune bleeding disorder, immune thrombocytopenic

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA